September 2023
1. FERNANDEZ S, Diaz E, Rita CG, Estevez M, et al
   BET inhibitors induce NF-kappaB and E2F downregulation in Hodgkin and Reed-Sternberg cells.
   Exp Cell Res. 2023;430:113718.
   

   >> Share

   
   April 2022
2. NIE D, Xiao X, Chen J, Xie S, et al
   Prognostic and therapeutic significance of XPO1 in T-cell lymphoma.
   Exp Cell Res. 2022;416:113180.
   

   >> Share

   
   November 2021
3. DAI R, Wu M, Zhang Y, Zhu Z, et al
   G protein nucleolar 3 promotes Non-Hodgkin lymphoma progression by activating the Wnt/beta-catenin signaling pathway.
   Exp Cell Res. 2021;409:112911.
   

   >> Share

   
   September 2021
4. WANG B, Zheng B, Cao L, Liao K, et al
   T-lymphoma invasion and metastasis 1 promotes invadopodia formation and is regulated by the PI3K/Akt signaling pathway in hepatocellular carcinoma.
   Exp Cell Res. 2021 Sep 3:112806. doi: 10.1016/j.yexcr.2021.112806.
   

   >> Share

   
   August 2021
5. LIN R, Li X, Wu S, Qian S, et al
   Suppression of latent transforming growth factor-beta (TGF-beta)-binding protein 1 (LTBP-1) inhibits natural killer/ T cell lymphoma progression by inactivating the TGF-beta/Smad and p38(MAPK) pathways.
   Exp Cell Res. 2021 Aug 18:112790. doi: 10.1016/j.yexcr.2021.112790.
   

   >> Share

   
   
6. YANG Y, Zou P, He L, Shao J, et al
   CBL aggravates Ang II-induced cardiac hypertrophy via the VHL/HIF-1alpha pathway.
   Exp Cell Res. 2021;405:112730.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share